Published in Phys Ther on October 01, 1976
Peripheral beta-adrenergic receptors concerned with tremor. Clin Sci (1967) 2.97
Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects. J Clin Pharmacol (1983) 1.76
The effect of chronic adrenergic receptor blockade on plasma renin activity in man. J Clin Endocrinol Metab (1972) 1.75
Effect of beta-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients. Acta Endocrinol (Copenh) (1968) 1.48
Suppression of essential tremor by propranolol: correlation of effect with drug plasma levels and intensity of beta-adrenergic blockade. Ann Neurol (1977) 1.36
Fulminant beriberi heart disease with lactic acidosis: presentation of a case with evaluation of left ventricular function and review of pathophysiologic mechanisms. Circulation (1978) 1.30
Propranolol therapy during pregnancy, labor, and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition. J Pediatr (1977) 1.28
The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses. Clin Pharmacol Ther (1982) 1.21
Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration. Gastroenterology (1984) 1.05
Clinical pharmacokinetics of verapamil. Clin Pharmacokinet (1984) 1.05
Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. Am J Cardiol (1981) 1.04
Failure of single-session dietary counseling to reduce salt intake in hypertensive patients. South Med J (1977) 0.99
Reversal of the cardiovascular effects of verapamil by calcium and sodium: differences between electrophysiologic and hemodynamic responses. Circulation (1979) 0.99
Effect of adrenergic receptor blockade on the responses to isometric handgrip: studies in normal and hypertensive subjects. J Cardiovasc Pharmacol (1980) 0.96
Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2. Diabetes Technol Ther (2002) 0.95
The pharmacology of verapamil. V. Tissue distribution of verapamil and norverapamil in rat and dog. Pharmacology (1983) 0.95
Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man. Circulation (1982) 0.94
Kinetics and dynamics of nifedipine after oral and sublingual doses. Am J Med (1986) 0.92
Measurement of nifedipine in plasma by gas--liquid chromatography and electron-capture detection. Clin Chem (1983) 0.92
Clinical pharmacology of slow channel blocking agents. Prog Cardiovasc Dis (1982) 0.89
Clinical pharmacokinetics of calcium channel antagonists. J Cardiovasc Pharmacol (1982) 0.89
Intravenous verapamil for termination of re-entrant supraventricular tachycardias: intracardiac studies correlated with plasma verapamil concentrations. Ann Intern Med (1980) 0.89
Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations. Circulation (1978) 0.89
Malignant hypertension: effect of therapy on renin and aldosterone. Circ Res (1971) 0.88
Effect of nifedipine on gastric emptying in normal subjects. Dig Dis Sci (1985) 0.87
Fluorometric assay of verapamil in biological fluids and tissues. J Pharm Sci (1976) 0.87
Plasma renin activity in chronic plumbism. Effect of treatment. Arch Intern Med (1971) 0.87
Efficacy of verapamil in exercise-induced ventricular tachycardia. Am J Cardiol (1985) 0.86
Improving the effect of FDA-mandated drug safety alerts with Internet-based continuing medical education. Curr Drug Saf (2013) 0.85
Intravenous propranolol administration: a method for rapidly achieving and sustaining desired plasma levels. Clin Pharmacol Ther (1976) 0.84
Tricuspid regurgitation following inferior myocardial infarction. Arch Intern Med (1976) 0.83
Verapamil plasma levels and ventricular rate response in patients with atrial fibrillation and flutter. Clin Pharmacol Ther (1979) 0.83
Pharmacokinetics of calcium-entry blockers. Am J Cardiol (1985) 0.83
Macroglossia--a positional complication. Anesthesiology (1974) 0.82
Peripheral beta-receptor responsiveness in patients with essential hypertension. Arch Intern Med (1979) 0.82
Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine. J Pharmacol Exp Ther (1984) 0.82
Effects of hypothermia on propranolol kinetics. Clin Pharmacol Ther (1979) 0.81
Studies of experimental cervical spinal cord transection. Part II: Plasma norepinephrine levels after acute cervical spinal cord transection. J Neurosurg (1979) 0.81
Verapamil-induced changes in central conduction in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (1985) 0.81
Effect of hypothermia on drug metabolism. In vitro studies with propranolol and verapamil. Pharmacology (1980) 0.81
Correlation of plasma levels of nifedipine and cardiovascular effects after sublingual dosing in normal subjects. J Clin Pharmacol (1985) 0.79
Age-related changes in drug handling in man. Am J Cardiol (1986) 0.79
Malignant hypertension due to renal artery stenosis. Greater renin release from the nonstenotic kidney. JAMA (1972) 0.79
The pharmacology of verapamil. III. Pharmacokinetics in normal subjects after intravenous drug administration. J Cardiovasc Pharmacol (1981) 0.79
The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram. J Pharmacol Exp Ther (1977) 0.78
Fever, tachycardia, and hypertension with acute catatonic schizophrenia. Arch Intern Med (1978) 0.78
Studies of experimental cervical spinal cord transection. Part IV: Effects of cervical spinal cord transection on myocardial blood flow in anesthetized dogs. J Neurosurg (1980) 0.78
Studies of experimental cervical spinal cord transection. Part III: Effects of acute cervical spinal cord transection on cerebral blood flow. J Neurosurg (1979) 0.77
Measurement of verapamil concentrations in plasma by gas chromatography and high pressure liquid chromatography. Ther Drug Monit (1980) 0.77
The effects of verapamil and lidocaine on the automatic depolarizations in guinea-pig ventricular myocardium. J Pharmacol Exp Ther (1978) 0.77
Absence of slow channel-dependent conduction within the His-Purkinje (bundle branch) reentrant circuit: a clinical and experimental study of the effects of verapamil. Am J Cardiol (1982) 0.77
Effect of intravenous furosemide on the renal excretion of digoxin. J Clin Pharmacol (1976) 0.77
Cardiovascular and pharmacokinetic consequences of combined administration of verapamil and propranolol in dogs. Am J Cardiol (1985) 0.76
Effects of intravenous and oral verapamil upon pressor and adrenal steroidogenic responses in normal man. J Clin Endocrinol Metab (1983) 0.76
Effect of verapamil on retrograde conduction in atrioventricular nodal reentrant tachycardia. Am J Cardiol (1984) 0.76
Aspects of the clinical pharmacology of verapamil, a calcium-entry antagonist. Biopharm Drug Dispos (1983) 0.75
Effect of beta-adrenergic blockade on hypothermia-induced hypokalemia. Surg Forum (1977) 0.75
Effect of treadmill exercise testing on serum enzymes and the resting electrocardiogram. Can Med Assoc J (1975) 0.75
A multicenter comparison of isradipine and prazosin for treatment of essential hypertension. Cardiovasc Drugs Ther (1990) 0.75
Medical admissions to a teaching service: a six months' review in a veterans hospital. South Med J (1974) 0.75
Hypertensive crisis and myocardial infarction after fluorescein angiography. South Med J (1981) 0.75
Effects of phenobarbital and SKF-525A on in vitro hepatic metabolism of verapamil and nifedipine. Pharmacology (1985) 0.75
Hypertension and neurofibromatosis. Case report. Hypertension (1983) 0.75
The possible role of antiarrhythmic drugs in the prevention of sudden death. Heart Lung (1973) 0.75
The use of exercise in diagnosis and treatment of cardiac patients in a community hospital: experience over 27 months. J Ky Med Assoc (1976) 0.75
Nifedipine-propranolol interaction: dependence of cardiovascular effects on plasma drug concentrations. J Cardiovasc Pharmacol (1987) 0.75
Identification of central trigeminal nociceptors and the effects of nitrous oxide. Anesthesiology (1973) 0.75
GLC assay of verapamil in plasma: identification of fluorescent metabolites after oral drug administration. J Pharm Sci (1979) 0.75
Effect of hypothyroidism on parasitemia and survival in rodent malaria. Am J Med Sci (1974) 0.75
Chronic salt excess and hypertension. A cultural epidemic. J Tenn Med Assoc (1971) 0.75
Suppression of essential tremor by propranolol: correlation of effect with intensity of beta-adrenergic blockade. Trans Am Neurol Assoc (1976) 0.75
Guanethidine in antihypertensive therapy: experience with an oral loading regimen. J Clin Pharmacol (1976) 0.75
Plasma concentrations and hemodynamic effects of nifedipine: a study in anesthetized dogs. J Cardiovasc Pharmacol (1984) 0.75
Physical therapists in private practice. Report of a survey. Phys Ther (1967) 0.75
Clinical implications of patient-provider agreements in opioid prescribing. Curr Drug Saf (2015) 0.75
Pharmacology of verapamil. II. Impairment of glucose tolerance by verapamil in the conscious dog. Pharmacology (1980) 0.75
Pharmacodynamic comparison of verapamil and nifedipine in anesthetized dogs. J Cardiovasc Pharmacol (1985) 0.75
Nifedipine stability in cardioplegic solution. Am J Hosp Pharm (1984) 0.75
Effects of verapamil on the arrhythmogenic action of acetylstrophanthidin. Pharmacology (1984) 0.75
Cardiodepressant actions of combined diltiazem and propranolol in dogs. J Cardiovasc Pharmacol (1994) 0.75
Hemodynamic and pharmacokinetic aspects of the interactions between verapamil and pindolol. Pharmacology (1987) 0.75
Contrasting effects of verapamil and procainamide on intraventricular conduction and reentry within the His-Purkinje system in man. Acta Cardiol (1982) 0.75
Obstetric anesthesia--a two-way street. JOGN Nurs (1976) 0.75
Aspects of the clinical pharmacology of nifedipine, a dihydropyridine calcium-entry antagonist. Biopharm Drug Dispos (1986) 0.75
Negative inotropic effect of intravenous nifedipine in coronary artery disease: relation to plasma levels. Am Heart J (1990) 0.75
Endocarditis on prosthetic mitral valves. Fatal obstruction to left ventricular inflow. Chest (1974) 0.75
Kinetics and dynamics of calcium entry antagonists in systemic hypertension. Am J Cardiol (1986) 0.75
Effects of antihypertensive drug therapy on responses to isometric exercise. South Med J (1981) 0.75
Particle size distribution of radium-containing phosphor powders. Health Phys (1973) 0.75
Studies of experimental cervical spinal cord transection. Part I: Hemodynamic changes after acute cervical spinal cord transection. J Neurosurg (1978) 0.75
Painless myocardial infarctions after coronary bypass operation. South Med J (1974) 0.75